Why get the HPV 9-valent vaccine?
Jan 30, 2023
Source: Cainiu Health
Dr. Lv Aiming
Introduction
The 9-valent HPV vaccine is an effective vaccine for preventing cervical cancer. It protects against nine types of the virus—types 6, 11, 16, 18, 31, 33, 45, 52, and 58—and is recommended for females aged 9 to 45. A total of three doses are required, and the vaccine can prevent over 90% of cervical cancer cases. Cervical cancer is a serious disease, and the 9-valent HPV vaccine offers effective protection against it.
The term "nine-valent" in medicine refers to the nine-valent HPV vaccine. The primary purpose of receiving the nine-valent HPV vaccine is to prevent cervical cancer caused by human papillomavirus (HPV) infection.
The nine-valent HPV vaccine is an effective vaccine for preventing cervical cancer. It protects against nine HPV types—6, 11, 16, 18, 31, 33, 45, 52, and 58. It is recommended for females aged 9 to 45 years, requiring a total of three doses, and can prevent over 90% of cervical cancer cases. Cervical cancer is the most common gynecological malignant tumor. The peak incidence of carcinoma in situ occurs between ages 30 and 35, while invasive cancer typically develops between ages 45 and 55. In its early stages, this disease often presents no obvious symptoms. Without timely treatment, it may lead to vaginal bleeding, abnormal discharge, as well as urinary frequency, urgency, constipation, and lower limb pain and swelling. It is considered a serious condition that significantly affects health. The nine-valent HPV vaccine effectively prevents cervical cancer and thus contributes to maintaining overall health.
It should be noted that individuals with acute fever, those who are pregnant, or those who have previously received the quadrivalent HPV vaccine should not receive the nine-valent HPV vaccine.
